Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Craigbadon Dec 21, 2016 4:14pm
176 Views
Post# 25631882

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Tax loss selling?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Tax loss selling?Go ahead and look up outstanding warrants, rsu's, options, etc and you may be suprised at the outlandlish number that are deep in the money right now. Feel free to post them to the board if you're so sure of yourself. Its not as much unloading for a quick buck as you say but balancing the portfolio. If a hedge fund or mm has some deep in the money warrants and maintains a 5% weighting in Pli, selling their position to exercise their warrants may simply mean they pocket a bunch of cash and maintain their portfolio weighting. Its neither pumping or bashing, although the seeking alpha article did draw attention to a momentum short the likely need for cash in the first quarter certainly suggests there may be more downside. Not even gonna argue the science, it may be fine. Only hoping the direction stays the same for the next while.

stockbuphoon wrote: Wyndewest,

You're replying to a shorter (CraigBad) similar to EddySantana who both came on this PLI board the same day as BlackMamba posted the article of lies and half truths. Asking for their opinion will only get you the most negative possible scenario of all their institutional supporters selling their warrants well under the recent financing level to "unload and make a buck" providing  huge supply. I am sure RBC and Thomvest is just unloading as quick as they can like day traders. Come on, people. Big hedgees are sorting and then after cheap shares down here. You're lobbing slow pitches for these scumbags to bash the company. They know little about the company and cannot even understand King Cobra's rebuttal. I would be careful to not to heed their advice as they may convince you that PLI has not produced amazing results in past 3 years in clinic and that we are not on our way to partnerships and much bigger revenue in 2017 with a boatload of cash in bank like never before. But, hey, that's just a suggestion. Follow the spanking brand newbees if you want. 


Bullboard Posts